From the Wires
TongLi Pharmaceuticals Announces Distribution of Ginshen Wubao, a New Dietary Food Supplement
By: PR Newswire
Jan. 3, 2013 01:54 PM
PRINCETON, N.J., Jan. 3, 2013 /PRNewswire/ -- TongLi Pharmaceuticals (USA), Inc. (OTCQB: TGLP) today announced that the company has successfully manufactured and will distribute Ginshen Wubao, a dietary food supplement to the domestic and oversea health care markets. Researches indicated that the ingredients of the Ginshen Wubao can support human immunity. The Ginshen Wubao is a TongLi's exclusive patented product.
The Ginshen Wubao can support human immunity, especially for aged people and valetudinarianism. The Ginshen Wubao also has significant benefits to improve amnesia and insomnia. If you are pregnant, nursing or a child please consult your healthcare practitioner before taking this dietary supplement.
The Ginshen Wubao contains extracts from American Ginseng and Fo-Ti roots. Ginsenosides can tonify Qi and Ying. Fo-Ti extracts can nourish hepatorenal functions, strengthen physique and blacken beard and hair as well as reduce hyperlipidemia.
The Ginshen Wubao is scientifically formulated, manufactured with advanced processing technic and high quality standards. Long-term taking the Ginshen Wubao can improve body's functions. The product does not have obvious adverse effects.
The Ginshen Wubao is a daily-taking food supplement which can support immunity, improve body performance and prevent diseases. Currently, the world aging population is fast growing. Aged people are undergoing degeneration of body performance and decrease of immunity therefore they need not only to adjust daily life style but also to take food supplements to facilitate their body performance. The Ginshen Wubao is a food supplement that can support your immunity and enhance body performance, consequently help to prevent diseases. For valetudinarianism, the Ginshen Wubao can help to restore immunity and alleviate deterioration of diseases. The Ginshen Wubao is suitable for both young and old people, easily taken and has no obvious adverse effects, suits the Asian to take especially therefore it has huge market potential and considerable prospects.
SOURCE TongLi Pharmaceuticals (USA), Inc.
Latest Cloud Developer Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week
Breaking Cloud Computing News